By inhibiting a specific enzyme, the drug
celecoxib can reduce the number of colon polyps in patients with a
hereditary disease that causes hundreds of the precancerous growths,
according to new research. The drug could impact polyp growth in the general
population, but further research is needed to determine that, say
experts.